Rashkin, Sara R. http://orcid.org/0000-0001-5542-6891
Graff, Rebecca E. http://orcid.org/0000-0003-0316-8303
Kachuri, Linda
Thai, Khanh K.
Alexeeff, Stacey E.
Blatchins, Maruta A.
Cavazos, Taylor B. http://orcid.org/0000-0003-3537-2608
Corley, Douglas A.
Emami, Nima C.
Hoffman, Joshua D.
Jorgenson, Eric http://orcid.org/0000-0002-5829-8191
Kushi, Lawrence H. http://orcid.org/0000-0001-9136-1175
Meyers, Travis J.
Van Den Eeden, Stephen K. http://orcid.org/0000-0002-5599-8387
Ziv, Elad
Habel, Laurel A.
Hoffmann, Thomas J. http://orcid.org/0000-0001-6893-4449
Sakoda, Lori C. http://orcid.org/0000-0002-0900-5735
Witte, John S.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA088164, R01CA201358, R25CA112355, K07CA188142, K24CA169004, U01CA127298)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 2 January 2020
Accepted: 13 August 2020
First Online: 4 September 2020
Competing interests
: J.S.W. is a non-employee co-founder of Avail.bio and serves as an expert witness for Pfizer and Sanofi. All other authors declare no competing interests.